New methods of tumor detection carcinogenic, are extremely important to fight this disease that, until then, has numerous treatments, but no cure. We will talk more about this new methodology detection of types of cancer.
Read more:Potatoes may be key to curing cancer, say scientists
see more
'Barbie' movie predicted to boost Mattel profits…
Japanese company imposes time restriction and reaps benefits
New ways to identify cancer in the body
It is possible to detect more than 10 types of cancer in urine and blood samples. These new tests are specific tests for each type of cancer, so patients will need to be tested separately for each disease.
about the study
Studies have already shown that these tests have the ability to detect twice as many people with stage 1 cancer compared to those done based on DNA. This method detects the various types of cancer at an early stage, helping to increase the survival rates of tested patients.
The international team that developed this new method based on detecting changes in sugars glycosaminoglycans, uses a technique in which algorithms are used to ascertain some type of change found in sugars. The test is done through small samples of blood and urine, which makes it much more accessible.
In previously diagnosed people and in other considerably healthy people, this new method detected 14 types of cancer. Through the same samples used for the detection of these cancers, it is possible to detect many other types of tumors at an early stage.
It is possible to identify the effectiveness of this new method from the moment in which it is possible to detect the disease in stage 1 very more accurately than the results obtained through methods such as MCED - Early Multicancer Detection, which are based on DNA.
This method offers hope that one day it will be possible to detect all types of cancer more easily.
But of course we have to keep our feet on the ground; scholars themselves say that it is necessary to have other new tools for this feat.
And the other limitation in this case is the sensitivity of only 10% in detecting stage 1 cancers and also the impossibility of detecting other variations of the disease, such as brain tumors.
Independently, the method presented itself as a possibility to expand the chance of a better early detection of cancer.
